DexCom logo

DexCom

DXCM | NASDAQ
Chart Builder DCF Calculator
$81.61
-$1.72 (-2.06%)
At close: Nov 16, 2026, 4:00 PM ET
$81.84
+$0.23 (+0.28%)
After-hours: Nov 16, 2026, 7:49 PM ET
-2.06%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
84.4
+1.5 pts
Fundamentals Excellent
Market Sentiment Bullish
Moat Wide
Sector Rank #7/1021 (Top 1%)

Key Statistics

Market Data

Market Cap $30.44B
1D Range
81.46 83.75
52W Range
57.56 92.34

Valuation (TTM)

PE 32
PB 12.00
EV/EBITDA 19.35

Valuation (NTM)

Forward PE 30.86
Forward PEG 1.03
Price Target $96.00
Loading financial charts...

Profile

DexCom, Inc. is a medical technology company primarily focused on innovating, developing, and marketing continuous glucose monitoring (CGM) systems. Operating across the United States and internationa...

Sector Healthcare
Employees 11,050
IPO Date Apr 14, 2005
Fiscal Year January - December

Latest News

Here's Why You Should Retain DexCom Stock in Your Portfolio for Now

3 days ago · zacks.com

Here's Why You Should Retain DexCom Stock in Your Portfolio for Now
Dexcom Announces Upcoming Conference Presentation

6 days ago · businesswire.com

Dexcom Announces Upcoming Conference Presentation
DexCom to Launch 15-Day G7 CGM System in Canada This November

14 days ago · zacks.com

DexCom to Launch 15-Day G7 CGM System in Canada This November
DexCom: Improving Patient Access Makes It A Long-Term Buy

15 days ago · seekingalpha.com

DexCom: Improving Patient Access Makes It A Long-Term Buy
DexCom Stock Up on Q3 Earnings & Revenue Beat, Margins Rise

18 days ago · zacks.com

DexCom Stock Up on Q3 Earnings & Revenue Beat, Margins Rise
DexCom, Inc. (DXCM) Q3 2026 Earnings Call Transcript

18 days ago · seekingalpha.com

DexCom, Inc. (DXCM) Q3 2026 Earnings Call Transcript
What DexCom (DXCM) Said on Its Q3 Earnings Call

18 days ago · marketbeat.com

What DexCom (DXCM) Said on Its Q3 Earnings Call
DexCom (DXCM) Surpasses Q3 Earnings and Revenue Estimates

18 days ago · zacks.com

DexCom (DXCM) Surpasses Q3 Earnings and Revenue Estimates
DexCom Q3 2026 Earnings Call Transcript

18 days ago · benzinga.com

DexCom Q3 2026 Earnings Call Transcript
Diabetes Wearable-Maker Handily Beats Earnings Views, Hikes Sales Guide

18 days ago · investors.com

Diabetes Wearable-Maker Handily Beats Earnings Views, Hikes Sales Guide

Earnings

Latest Earnings
Oct 29, 2026
EPS
$0.73
Beat +8.15%
REV
$1.34B
Beat +1.18%
Next Earnings
Feb 11, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
20
Consensus
Buy
Price Target
$96.00
Upside
+17.63%
Buy (19)
Hold (1)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.